We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$811M
AUM Growth
+$71.2M
Cap. Flow
+$48M
Cap. Flow %
5.92%
Top 10 Hldgs %
28.89%
Holding
102
New
7
Increased
37
Reduced
34
Closed
10

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$18.2M
2
BDX icon
Becton Dickinson
BDX
+$16.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$14.2M
4
CELG
Celgene Corp
CELG
+$13M
5
CI icon
Cigna
CI
+$12.6M

Top Sells

Rank Stock Value
1
ADMS
Adamas Pharmaceuticals
ADMS
+$15.2M
2
NKTR icon
Nektar Therapeutics
NKTR
+$12.5M
3
ESPR
Esperion Therapeutics
ESPR
+$10.4M
4
COR icon
Cencora
COR
+$6.72M
5
UHS icon
Universal Health Services
UHS
+$5.94M

Sector Composition

Rank Sector Weight
1 Healthcare 94.68%
2 Technology 0.23%
3 Energy 0.22%
4 Financials 0.18%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTPH
101
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-8,045
Closed -$1.01M
JUNO
102
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-109,430
Closed -$5M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Rhenman & Partners Asset Management held 102 positions worth $811M, up 9.6% from $740M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Rhenman & Partners Asset Management deployed $48M of net new capital in Q1 2018, opening 7 new positions and adding to 37 existing holdings. Its largest new stake was CVS Health: 253,868 shares worth $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 90% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Adamas Pharmaceuticals, an estimated $15.2M trimmed.

  • Rhenman & Partners Asset Management's largest Q1 2018 buy was CVS Health: 253,868 shares worth $15.8M.
  • Rhenman & Partners Asset Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $14.2M increase.
  • Rhenman & Partners Asset Management's biggest Q1 2018 reduction was Adamas Pharmaceuticals, cutting an estimated $15.2M.
  • Rhenman & Partners Asset Management fully exited Universal Health Services in Q1 2018, selling an estimated $5.94M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 29% of its $811M portfolio in Q1 2018.
  • Rhenman & Partners Asset Management opened 7 new positions and closed 10 in Q1 2018.
  • Rhenman & Partners Asset Management's portfolio value rose 9.6% quarter-over-quarter to $811M.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2018, filed 11 Apr 2018.